Admission Cardiac Diagnostic Testing with Electrocardiography and Troponin Measurement Prognosticates Increased 30‐Day Mortality in COVID‐19

Timothy J. Poterucha(Columbia University Irving Medical Center), Elaine Y. Wan(NewYork–Presbyterian Hospital), J. Fried(NewYork–Presbyterian Hospital), Frederick Ehlert(Columbia University Irving Medical Center), Nir Uriel(New York Proton Center), John Morrow(Columbia University), Hannah Rosenblum(NewYork–Presbyterian Hospital), José Dizon(Columbia University Irving Medical Center), Kevin J. Clerkin(Columbia University), Adler Perotte(Columbia University), Hasan Garan(NewYork–Presbyterian Hospital), Björn Redfors(Cornell University), Jan M. Griffin(Medical University of South Carolina), Angelo Biviano(Columbia University), Sneha S. Jain(Palo Alto University), Daniel Burkhoff(Columbia University Irving Medical Center), Allan Schwartz(NewYork–Presbyterian Hospital), J. Raikhelkar(NewYork–Presbyterian Hospital), Pierre Elias(Columbia University Irving Medical Center), Ersilia M. DeFilippis(Cornell University), Mathew S. Maurer(Alnylam Pharmaceuticals (United States)), Gabriel Sayer(Columbia University Irving Medical Center), Aakriti Gupta, Mahesh V. Madhavan(NewYork–Presbyterian Hospital), Deepak Saluja(Columbia University), Hirad Yarmohammadi(Columbia University), Andrea Kim(Columbia University Irving Medical Center), Matthew Lawlor(NewYork–Presbyterian Hospital), Martin B. Leon(Columbia University Irving Medical Center), LeRoy E. Rabbani(NewYork–Presbyterian Hospital)
Journal of the American Heart Association
November 10, 2020
Cited by 51


Related Papers